WORX SCWorx Corp

SCWorx Announces an Annual Data Management Contract with a Leading Cancer Research Institute

SCWorx Announces an Annual Data Management Contract with a Leading Cancer Research Institute

NEW YORK, March 30, 2020 (GLOBE NEWSWIRE) -- SCWorx Corp. (Nasdaq: WORX) announced today it has signed a new renewable annual data management contract with one of the Northeast’s leading Cancer Institutes. The contract calls for $135,000 in year 1 and $110,000 annually thereafter, subject to automatic renewal and earlier termination.  SCWorx is deploying its “Cornerstone” data intelligence services, which utilizes highly evolved data to provide instantaneous normalization, repair and expansion of raw line item level transactional data produced by foundational systems such as MMIS, EMR and billing systems. Cornerstone instantly returns the highly-accurate and extended content directly to decision support databases to enable existing BI (Business Intelligence) tools and experienced personnel to produce unparalleled, auditable focused insights.

Marc Schessel , CEO of SCWorx stated, “SCWorx continues to decrease the time to delivery of actionable analytics and other data management solutions. Cornerstone was developed to be the first step for hospitals to use SCWorx’s powerful data management solutions and prepare their management teams for additional data services in the future. The platform proves its ROI and assists in SCWorx’s next stage rollouts for the senior management in hospitals.”

About SCWorx Corp.



SCWorx has created The Ultraverse Platform™, an advanced attributed virtualized item data warehouse (“VDW”) utilizing machine learning and artificial intelligence in order to offer a suite of software-as-a-service based solutions for healthcare providers. The value proposition for customers revolves around all solution modules being fully integrated with the VDW platform. The solution modules include Virtual Item Master, contract management and request for pricing (RFP) module, automated rebate management module, data interoperability (EMR, MMIS, finance) module, Automated Item Add Portal, Virtual General Ledger, and the data analytics module. SCWorx’s Ultraverse Platform™ creates a single source for information for healthcare providers’ data governance and data analytics for executives.

Forward-Looking Statements



This press release contains “forward-looking statements” that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations, future contract renewals and terminations, future financial position, prospects, plans and objectives of management are forward-looking statements. You can identify many (but not all) such forward-looking statements by looking for words such as “assumes,” “approximates,” “believes,” “expects,” “anticipates,” “estimates,” “projects,” “seeks,” “intends,” “plans,” “could,” “would,” “may” or other similar expressions. You should not place undue reliance on these forward-looking statements. Such statements are based on management’s current expectations and involve risks and uncertainties. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors, including, without limitation, securing future contracts and containing costs, the ability to project future cash utilization and reserves needed for contingent future liabilities and business operations, the availability of sufficient resources of the company to meet its business objectives and operational requirements and other important factors that are detailed in filings with the Securities and Exchange Commission made from time to time by SCWorx, including its Annual Report on Form 10-K for the year ended December 31, 2018, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Matters described in forward-looking statements may also be affected by other known and unknown risks, trends, uncertainties and factors, many of which are beyond the company’s ability to control or predict. SCWorx undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contacts:

Marc Schessel

Investor Contact:

Scott Gordon

President

CORE IR

516 222 2560

Media Contact:

Jules Abraham

Director of Public Relations

CORE IR

917-885-7378

Source: SCWorx Corp.

EN
30/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SCWorx Corp

 PRESS RELEASE

SCWorx Reminds Stockholders of Annual Meeting

SCWorx Reminds Stockholders of Annual Meeting New York, NY, Dec. 12, 2024 (GLOBE NEWSWIRE) -- SCWorx Corp., a Delaware corporation (the “Company”), reminds its stockholders that its 2024 Annual Meeting of Stockholders will be held 9:00 AM EST on December 23, 2024, at the Regus Conference Room at 35 Village Rd, Suite 100, Middleton, MA 01949, as per the Proxy Material mailed to shareholders on December 6, 2024. Contacts: ### Source: SCWorx Corp.

 PRESS RELEASE

SCWorx Announces Compliance with Nasdaq’s Periodic Reporting Listing S...

SCWorx Announces Compliance with Nasdaq’s Periodic Reporting Listing Standard NEW YORK, N.Y., Nov. 20, 2024 (GLOBE NEWSWIRE) -- SCWorx Corp. (Nasdaq: WORX) (the “Company”), a provider of data management services to healthcare providers, announced today that it has regained compliance with The Nasdaq Stock Market’s (“Nasdaq”) continued listing requirements regarding periodic reporting. On April 17, May 17, and August 19, 2024, Nasdaq notified the Company that it no longer met the Nasdaq’s periodic filing requirement under Listing Rule 5250(c)(1) (the “Rule”). In a letter dated October 1...

 PRESS RELEASE

SCWorx Announces Completion of Equity Financing with Institutional Inv...

SCWorx Announces Completion of Equity Financing with Institutional Investors New York, NY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- SCWorx Corp (the “Company”), on November 19th, 2024 completed an equity financing with institutional investors (the “Institutional Investors” or “Investors”). In connection with the funding, the Company sold an aggregate of 232,558 shares of common stock and warrants to purchase the same number of shares of common stock, for aggregate gross proceeds of $200,000. The Company will be registering for resale the shares of common stock and warrant shares with U.S. Secu...

 PRESS RELEASE

SCWorx Corp. Receives Notice of Non-Compliance from NASDAQ Stock Marke...

SCWorx Corp. Receives Notice of Non-Compliance from NASDAQ Stock Market Pertaining to its 10-Q for the quarter ended June 30, 2024 NEW YORK, N.Y., Aug. 23, 2024 (GLOBE NEWSWIRE) -- On August 19, 2024, the Nasdaq Stock Market notified SCWorx Corp. (the “Company”) that it has failed to satisfy a standard for continued listing, namely Nasdaq Listing Rule 5250(c)(1) (the “Rule), because the Company did not file its June 30, 2024 Quarterly Report on Form 10-Q by the due date of August 14, 2024 and because it remains delinquent in filing its Form 10-K for the period ended December 31, 2023 and...

 PRESS RELEASE

SCWorx Corp. Receives Notice from NASDAQ Stock Market Pertaining to it...

SCWorx Corp. Receives Notice from NASDAQ Stock Market Pertaining to its 10-Q for the quarter ended March 31, 2024 NEW YORK, N.Y., May 21, 2024 (GLOBE NEWSWIRE) -- On May 17, 2024, SCWorx Corp. (the “Company”) received a further notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) indicating that, as a result of not having timely filed its Form 10-Q for the period ended March 31, 2024, and because it remains delinquent in filing its Form 10-K for the year ended December 31, 2023, the Company has failed to satisfy a standard for continued listing, namely  Nasdaq Listing Rule ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch